We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VZ:NYSEVerizon Communications Inc. Analysis

Data as of 2026-09-01 - not real-time

$50.29

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

At $50.29, Verizon Communications Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. Over a rolling month the price has gained 14.9%. With RSI at 66.5 the momentum picture is approaching overbought, alongside a bullish MACD signal. The recent range runs from support at $45.09 up to resistance at $50.92.
On valuation the read is fair — earnings multiple of 13.1 versus a 16.1 sector average, below the peer group. The 5.65% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 24.9%, a beta of -0.28 and a maximum drawdown of 18.3%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 5/10.

Top Market Events

Seeking Alpha1monVerizon holds near flat after Q2 earnings beat and guidance boostVerizon Communications VZ reported...Telecommunications giant Verizon NYSE:VZ fell short of the market’s revenue expectations in Q2 CY2026, with sales...Telecommunications giant Verizon NYSE:VZ in Q2 CY2026, with sales flat year on year at $34.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 45.58
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 13.1 versus sector average of 16.1
  • Trading above the 200-day average of 45.58

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 13.1 versus sector average of 16.1
  • Revenue contracting at -0.7%
  • Return on equity of 15.8%

Key Metrics & Analysis

Financial Health

Revenue Growth-0.70%
Profit Margin11.64%
P/E Ratio13.1
ROE15.84%
ROA5.05%
Debt/Equity184.08
P/B Ratio2.0
Op. Cash Flow$38.8B
Free Cash Flow$17.5B
Industry P/E16.1

Technical Analysis

TrendBullish
RSI66.5
Support$45.09
Resistance$50.92
MA 20$48.68
MA 50$46.16
MA 200$45.58
MACDBullish
VolumeDecreasing
Fear & Greed Index94.02

Valuation

Fair Value$7.34
Target Price$51.56
Upside/Downside2.51%
GradeFair
TypeValue
Dividend Yield5.65%

Risk Assessment

Beta-0.28
Volatility24.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.